14.4 A Collaborative Psychiatric-Genetics Inpatient Care Delivery Model Improves Access to Clinical Genetic Evaluation, Testing, and Diagnosis for Patients With Neurodevelopmental Disorders

Abstract

The current American College of Medical Genetics and Genomics (ACMG) guidelines recommend genetic testing for all patients with neurodevelopmental disorders (NDDs) including ASD, intellectual disability, and global developmental delay. Even with strong evidence-based recommendations, there are many patients with NDDs who do not receive a clinical genetics evaluation or diagnostic testing for a variety of reasons, often complicated by a general lack of access to quality medical care for children with NDDs.